Monthly
US$200
Billed every month
Sign in to subscribeAzilsartan Medoxomil Potassium Tablets
As of 13 November 2026, for Azilsartan Medoxomil Potassium Tablets, 35 applications are listed as under review at China's CDE; 9 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 25 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 2 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders25View records ↓
Under-review filings35View records ↓
This year’s generic filers9View records ↓
NHSA approval numbers50View records ↓
API companies with A status13View records ↓
Chemical-drug catalogue
Loaded records: 25 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 24 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20265138 | 2026/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20265137 | 2026/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | 2026/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | 2026/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized | Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20264859 | 2026/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized | Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20264858 | 2026/06/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20264463 | 2026/05/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264452 | 2026/05/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264453 | 2026/05/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20264462 | 2026/05/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264261 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264262 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Guo Gao Pharma Co., Ltd. romanized | Jiangsu He Chen Pharma Co., Ltd. romanized | 国药准字H20264267 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Guo Gao Pharma Co., Ltd. romanized | Jiangsu He Chen Pharma Co., Ltd. romanized | 国药准字H20264266 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264151 | 2026/04/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264152 | 2026/04/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20264139 | 2026/04/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20264138 | 2026/04/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264006 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264005 | 2026/04/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20263309 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20263310 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20256376 | 2025/12/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20256375 | 2025/12/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ren He Yi Kang Group Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20256241 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ren He Yi Kang Group Co., Ltd. romanized | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20256242 | 2025/12/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Mu Yuan (Anhui) Pharma Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20255997 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Mu Yuan (Anhui) Pharma Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20255998 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20255981 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20255982 | 2025/11/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | Shandong Yao Shi Pharma Co., Ltd. romanized | 国药准字H20255913 | 2025/11/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | Shandong Yao Shi Pharma Co., Ltd. romanized | 国药准字H20255912 | 2025/11/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255786 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255787 | 2025/10/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20255689 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20255688 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255630 | 2025/09/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255631 | 2025/09/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu He Chen Pharma Co., Ltd. romanized | Jiangsu He Chen Pharma Co., Ltd. romanized | 国药准字H20255268 | 2025/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu He Chen Pharma Co., Ltd. romanized | Jiangsu He Chen Pharma Co., Ltd. romanized | 国药准字H20255269 | 2025/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254938 | 2025/07/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253694 | 2025/03/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253695 | 2025/03/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Gui Lin Nan Yao Co., Ltd. romanized | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253641 | 2025/03/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Gui Lin Nan Yao Co., Ltd. romanized | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253642 | 2025/03/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244706 | 2024/08/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244707 | 2024/08/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Takeda Pharma A/S | Takeda Ireland Ltd. | 国药准字HJ20210004 | 2021/01/19 | See source | Imported originator drug | CDE |
| Takeda Pharma A/S | Takeda Ireland Ltd. | 国药准字HJ20210003 | 2021/01/19 | See source | Imported originator drug | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254939 | 2025/07/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 50 distinct approval numbers and 25 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244706 | See source | Category B | XC09CAM175A001010100177 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253695 | See source | Category B | XC09CAM175A001010101467 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264151 | See source | Category B | XC09CAM175A001010102353 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264856 | See source | Category B | XC09CAM175A001010102877 | NHSA |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20256376 | See source | Category B | XC09CAM175A001010103216 | NHSA |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264452 | See source | Category B | XC09CAM175A001010104394 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255630 | See source | Category B | XC09CAM175A001010104606 | NHSA |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20264462 | See source | Category B | XC09CAM175A001010104655 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20253641 | See source | Category B | XC09CAM175A001010105206 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20263309 | See source | Category B | XC09CAM175A001010105356 | NHSA |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264261 | See source | Category B | XC09CAM175A001010105805 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20255689 | See source | Category B | XC09CAM175A001010105847 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254938 | See source | Category B | XC09CAM175A001010109568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255787 | See source | Category B | XC09CAM175A001010179289 | NHSA |
| Takeda Pharma A/S | 国药准字HJ20210004 | See source | Category B | XC09CAM175A001010179422 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256241 | See source | Category B | XC09CAM175A001010183033 | NHSA |
| Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264006 | See source | Category B | XC09CAM175A001010183238 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010183521 | NHSA |
| Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264858 | See source | Category B | XC09CAM175A001010183644 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20255268 | See source | Category B | XC09CAM175A001010183879 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20264266 | See source | Category B | XC09CAM175A001010183883 | NHSA |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255981 | See source | Category B | XC09CAM175A001010183916 | NHSA |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255913 | See source | Category B | XC09CAM175A001010184183 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264138 | See source | Category B | XC09CAM175A001010184221 | NHSA |
| Mu Yuan (Anhui) Pharma Co., Ltd. romanized | 国药准字H20255998 | See source | Category B | XC09CAM175A001010184519 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244706 | See source | Category B | XC09CAM175A001010200177 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253695 | See source | Category B | XC09CAM175A001010201467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264856 | See source | Category B | XC09CAM175A001010202877 | NHSA |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264452 | See source | Category B | XC09CAM175A001010204394 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20253641 | See source | Category B | XC09CAM175A001010205206 | NHSA |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264261 | See source | Category B | XC09CAM175A001010205805 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254938 | See source | Category B | XC09CAM175A001010209568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255787 | See source | Category B | XC09CAM175A001010279289 | NHSA |
| Takeda Pharma A/S | 国药准字HJ20210003 | See source | Category B | XC09CAM175A001010279422 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256241 | See source | Category B | XC09CAM175A001010283033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010283521 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20255268 | See source | Category B | XC09CAM175A001010283879 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20264266 | See source | Category B | XC09CAM175A001010283883 | NHSA |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255981 | See source | Category B | XC09CAM175A001010283916 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253695 | See source | Category B | XC09CAM175A001010301467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264856 | See source | Category B | XC09CAM175A001010302877 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254938 | See source | Category B | XC09CAM175A001010309568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255787 | See source | Category B | XC09CAM175A001010379289 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256241 | See source | Category B | XC09CAM175A001010383033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010383521 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20255268 | See source | Category B | XC09CAM175A001010383879 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253695 | See source | Category B | XC09CAM175A001010401467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264856 | See source | Category B | XC09CAM175A001010402877 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256241 | See source | Category B | XC09CAM175A001010483033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010483521 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256241 | See source | Category B | XC09CAM175A001010583033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001010983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001011983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001012983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001013983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001014083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001014183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001014283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001014383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265037 | See source | Category B | XC09CAM175A001014483521 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244707 | See source | Category B | XC09CAM175A001020100177 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253694 | See source | Category B | XC09CAM175A001020101467 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264152 | See source | Category B | XC09CAM175A001020102353 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264857 | See source | Category B | XC09CAM175A001020102877 | NHSA |
| Xin Xiang Shi Chang Le Pharmaceutical Co., Ltd. romanized | 国药准字H20256375 | See source | Category B | XC09CAM175A001020103216 | NHSA |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264453 | See source | Category B | XC09CAM175A001020104394 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20255631 | See source | Category B | XC09CAM175A001020104606 | NHSA |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20264463 | See source | Category B | XC09CAM175A001020104655 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20253642 | See source | Category B | XC09CAM175A001020105206 | NHSA |
| Jiangxi Shimei Pharmaceutical Co., Ltd | 国药准字H20263310 | See source | Category B | XC09CAM175A001020105356 | NHSA |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264262 | See source | Category B | XC09CAM175A001020105805 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20255688 | See source | Category B | XC09CAM175A001020105847 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254939 | See source | Category B | XC09CAM175A001020109568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255786 | See source | Category B | XC09CAM175A001020179289 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256242 | See source | Category B | XC09CAM175A001020183033 | NHSA |
| Guangzhou Shi Lian Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20264005 | See source | Category B | XC09CAM175A001020183238 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020183521 | NHSA |
| Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264859 | See source | Category B | XC09CAM175A001020183644 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20255269 | See source | Category B | XC09CAM175A001020183879 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20264267 | See source | Category B | XC09CAM175A001020183883 | NHSA |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255982 | See source | Category B | XC09CAM175A001020183916 | NHSA |
| Jia Heng (Zhuhai Heng Qin) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255912 | See source | Category B | XC09CAM175A001020184183 | NHSA |
| Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264139 | See source | Category B | XC09CAM175A001020184221 | NHSA |
| Mu Yuan (Anhui) Pharma Co., Ltd. romanized | 国药准字H20255997 | See source | Category B | XC09CAM175A001020184519 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20244707 | See source | Category B | XC09CAM175A001020200177 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253694 | See source | Category B | XC09CAM175A001020201467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264857 | See source | Category B | XC09CAM175A001020202877 | NHSA |
| Hefei Li Fang Pharmaceutical Co., Ltd. romanized | 国药准字H20264453 | See source | Category B | XC09CAM175A001020204394 | NHSA |
| Gui Lin Nan Yao Co., Ltd. romanized | 国药准字H20253642 | See source | Category B | XC09CAM175A001020205206 | NHSA |
| Hainan Sai Li Ke Pharma Co., Ltd. romanized | 国药准字H20264262 | See source | Category B | XC09CAM175A001020205805 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254939 | See source | Category B | XC09CAM175A001020209568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255786 | See source | Category B | XC09CAM175A001020279289 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256242 | See source | Category B | XC09CAM175A001020283033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020283521 | NHSA |
| Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized | 国药准字H20255269 | See source | Category B | XC09CAM175A001020283879 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20264267 | See source | Category B | XC09CAM175A001020283883 | NHSA |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255982 | See source | Category B | XC09CAM175A001020283916 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253694 | See source | Category B | XC09CAM175A001020301467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264857 | See source | Category B | XC09CAM175A001020302877 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20254939 | See source | Category B | XC09CAM175A001020309568 | NHSA |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | 国药准字H20255786 | See source | Category B | XC09CAM175A001020379289 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256242 | See source | Category B | XC09CAM175A001020383033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020383521 | NHSA |
| Hefei Guo Gao Pharma Co., Ltd. romanized | 国药准字H20264267 | See source | Category B | XC09CAM175A001020383883 | NHSA |
| Hunan Hui Ze Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20255982 | See source | Category B | XC09CAM175A001020383916 | NHSA |
| Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | 国药准字H20253694 | See source | Category B | XC09CAM175A001020401467 | NHSA |
| Shanxi De Yuan Tang Pharma Co., Ltd. romanized | 国药准字H20264857 | See source | Category B | XC09CAM175A001020402877 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256242 | See source | Category B | XC09CAM175A001020483033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020483521 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20256242 | See source | Category B | XC09CAM175A001020583033 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001020983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001021983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001022983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001023983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001024083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001024183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001024283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001024383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20265038 | See source | Category B | XC09CAM175A001024483521 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264152 | See source | Category B | XC09CAM175A001030102353 | NHSA |
| Shaanxi Bai Lu Pharmaceutical Co., Ltd. romanized | 国药准字H20264152 | See source | Category B | XC09CAM175A001030202353 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 35 filings and 18 distinct first applicants.
Generic 35
New generic filings in 2026
Loaded records: 17 filings and 9 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hangzhou Duan Ben Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2600864 | Generic | 2026/04/15 | Not stated by source | CDE |
| Hangzhou Duan Ben Pharmaceuticals Technology Co., Ltd. romanized; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2600863 | Generic | 2026/04/15 | Not stated by source | CDE |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | CYHS2601306 | Generic | 2026/06/04 | Not stated by source | CDE |
| Suzhou Hong Sen Pharma Co., Ltd. romanized | CYHS2601305 | Generic | 2026/06/04 | Not stated by source | CDE |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | CYHS2601009 | Generic | 2026/04/30 | Not stated by source | CDE |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | CYHS2601008 | Generic | 2026/04/30 | Not stated by source | CDE |
| Guangdong Fang Sheng Jian Meng Pharma Co., Ltd. romanized; Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | CYHS2601133 | Generic | 2026/05/14 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized | CYHS2600324 | Generic | 2026/01/31 | Not stated by source | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized | CYHS2600323 | Generic | 2026/01/31 | Not stated by source | CDE |
| Shijiazhuang Gree Pharmaceutical Co., Ltd | CYHS2600215 | Generic | 2026/01/20 | Not stated by source | CDE |
| Shijiazhuang Gree Pharmaceutical Co., Ltd | CYHS2600214 | Generic | 2026/01/20 | Not stated by source | CDE |
| Hai Sen Biopharmaceuticals Co., Ltd. romanized; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CYHS2600120 | Generic | 2026/01/09 | Not stated by source | CDE |
| Hai Sen Biopharmaceuticals Co., Ltd. romanized; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CYHS2600119 | Generic | 2026/01/09 | Not stated by source | CDE |
| Shandong Xin Yi Pharmaceutical Co., Ltd. romanized | CYHS2600103 | Generic | 2026/01/09 | Not stated by source | CDE |
| Shandong Xin Yi Pharmaceutical Co., Ltd. romanized | CYHS2600102 | Generic | 2026/01/09 | Not stated by source | CDE |
| Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | CYHS2602776 | Generic | 2026/11/11 | Not stated by source | CDE |
| Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized | CYHS2602775 | Generic | 2026/11/11 | Not stated by source | CDE |
API registrations
Non-component matches: 13 companies with A status and 15 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 美阿沙坦钾 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20240001486 | I | Exact ingredient | 2026/07/07 | CDE |
| 美阿沙坦钾 · No verified English name | Lanzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Y20260000472 | I | Exact ingredient | 2026/06/12 | CDE |
| 美阿沙坦钾 · No verified English name | INIST ST Co., Ltd. | Y20250001453 | I | Exact ingredient | 2026/05/12 | CDE |
| 美阿沙坦钾 · No verified English name | Xu Chang Heng Sheng Pharmaceutical Co., Ltd. romanized | Y20260000355 | I | Exact ingredient | 2026/05/08 | CDE |
| 美阿沙坦钾 · No verified English name | Xu Zhou Wan Bang Jin Qiao Pharmaceutical Co., Ltd. romanized | Y20260000112 | I | Exact ingredient | 2026/02/28 | CDE |
| 美阿沙坦钾 · No verified English name | Shandong Xin Yi Pharmaceutical Co., Ltd. romanized | Y20250001339 | I | Exact ingredient | 2026/01/06 | CDE |
| 美阿沙坦钾 · No verified English name | Anhui Ai Li De Pharmaceutical Co., Ltd. romanized | Y20250001148 | I | Exact ingredient | 2025/11/11 | CDE |
| 美阿沙坦钾 · No verified English name | Shandong Yi Kang Pharma Co., Ltd. romanized | Y20250001028 | I | Exact ingredient | 2025/10/10 | CDE |
| 美阿沙坦钾 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20250001040 | I | Exact ingredient | 2025/10/10 | CDE |
| 美阿沙坦钾 · No verified English name | Shijiazhuang Gree Pharmaceutical Co., Ltd | Y20250000545 | I | Exact ingredient | 2025/09/05 | CDE |
| 美阿沙坦钾 · No verified English name | Fu An Pharma Group Ningbo Tian Heng Pharmaceutical Co., Ltd. romanized | Y20250000521 | I | Exact ingredient | 2025/06/06 | CDE |
| 美阿沙坦钾 · No verified English name | Hunan Fang Sheng Pharmaceutical Co., Ltd. romanized | Y20250000392 | I | Exact ingredient | 2025/05/15 | CDE |
| 美阿沙坦钾 · No verified English name | Suzhou Sheng Da Pharma Co., Ltd. romanized | Y20250000329 | A | Exact ingredient | 2026/10/10 | CDE |
| 美阿沙坦钾 · No verified English name | Zydus Takeda Healthcare Pvt. Ltd. | Y20250000342 | I | Exact ingredient | 2025/04/14 | CDE |
| 美阿沙坦钾 · No verified English name | Zhejiang Tian Yu Pharma Co., Ltd. romanized | Y20240001145 | A | Exact ingredient | 2026/06/17 | CDE |
| 美阿沙坦钾 · No verified English name | Anhui Jian Feng Bei Ka Pharma Co., Ltd. romanized | Y20240000741 | A | Exact ingredient | 2026/05/07 | CDE |
| 美阿沙坦钾 · No verified English name | Hefei Li Fang Pharmaceutical Co., Ltd. romanized | Y20240001141 | A | Exact ingredient | 2026/04/21 | CDE |
| 美阿沙坦钾 · No verified English name | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Y20240001210 | A | Exact ingredient | 2026/07/01 | CDE |
| 美阿沙坦钾 · No verified English name | Changchun Hai Yue Pharma Co., Ltd. romanized | Y20240000946 | I | Exact ingredient | 2025/07/18 | CDE |
| 美阿沙坦钾 · No verified English name | Hebei Guo Long Pharmaceutical Co., Ltd. romanized | Y20240000905 | A | Exact ingredient | 2026/11/08 | CDE |
| 美阿沙坦钾 · No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240000577 | A | Exact ingredient | 2025/09/30 | CDE |
| 美阿沙坦钾 · No verified English name | Hebei An Jian Cheng Yi Pharmaceuticals Technology Co., Ltd. romanized | Y20240000498 | A | Exact ingredient | 2025/12/04 | CDE |
| 美阿沙坦钾 · No verified English name | Wuhan Rui Cheng Pharma Co., Ltd. romanized | Y20240000076 | A | Exact ingredient | 2025/07/11 | CDE |
| 美阿沙坦钾 · No verified English name | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Y20240000038 | A | Exact ingredient | 2026/01/31 | CDE |
| 美阿沙坦钾 · No verified English name | Jiangxi Tong He Pharma Co., Ltd. romanized | Y20220001325 | A | Exact ingredient | 2026/05/20 | CDE |
| 美阿沙坦钾 · No verified English name | Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | Y20220000775 | I | Exact ingredient | 2023/12/26 | CDE |
| 美阿沙坦钾 · No verified English name | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Y20220000492 | A | Exact ingredient | 2025/05/17 | CDE |
| 美阿沙坦钾 · No verified English name | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20220000851 | A | Exact ingredient | 2026/09/18 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/11Accepted
Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized
CYHS2602776
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/11Accepted
Xin Shi Yang Guang Pharma (Hebei) Co., Ltd. romanized
CYHS2602775
Fact date: 2026/11/11 · Site observation date: 2026/11/12
View source ↗ -
2026/11/03No longer listed under review
Tianjin Hua Jin Pharmaceutical Co., Ltd. romanized
CYHS2502760
Fact date: 2026/11/03 · Site observation date: 2026/11/03
Accepted: 2025/07/31
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Azilsartan Medoxomil Potassium Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy